Therapeutic interventions in the progression of diabetic nephropathy.
Lewis
E J
EJ
Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL 60612.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D002216:Captopril / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D003404:Creatinine / Q000097:blood; D003928:Diabetic Nephropathies / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D004232:Diuretics / Q000627:therapeutic use; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000209:etiology; D008297:Male; D011446:Prospective Studies
D000319:Adrenergic beta-Antagonists; D004232:Diuretics; D002216:Captopril; D003404:Creatinine